Home
Browse
Search
Statistics
About
Usage
PMID: 17159598
Deeken JF, Figg WD, Bates SE, Sparreboom A
Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics.
Anticancer Drugs. 2007 Feb;18(2):111-26.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
178
ABCG2 p.Cys55Ala
X
ABCG2 p.Cys55Ala 17159598:178:248
status:
NEW
view ABCG2 p.Cys55Ala details
ABCB1 p.Gly449Ala
X
ABCB1 p.Gly449Ala 17159598:178:266
status:
NEW
view ABCB1 p.Gly449Ala details
Table 5 Ethnic frequency (%) of allelic variants in CYP2C9 Allelic variant SNPs Caucasians African-Americans Asians Hispanics Africans CYP2C9*2 C430T 6.8-13.2 1.0-2.5 0 8.0 CYP2C9*3 A1075C 4.3-15.9 0.5-1.25 0-2.2 6.0 CYP2C9*5 C1080G 0 1.7 CYP2C9*7
C55A
7.1 CYP2C9*8
G449A
6.7 7.1 CYP2C9*9 A752G 0.5 13.3 14.3 CYP2C9*11 C1003T 1 CYP2C9*12 C1465T 0.5 SNP, single nucleotide polymorphism. Sources: Caucasians [51-54], African Americans [52,54,55], Asians [52,56], Hispanics [57], Africans [52].
Login to comment
326
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17159598:326:59
status:
VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 17159598:326:39
status:
VERIFIED
view ABCG2 p.Val12Met details
ABCG2 p.Ile206Leu
X
ABCG2 p.Ile206Leu 17159598:326:81
status:
VERIFIED
view ABCG2 p.Ile206Leu details
ABCG2 p.Asn590Tyr
X
ABCG2 p.Asn590Tyr 17159598:326:106
status:
VERIFIED
view ABCG2 p.Asn590Tyr details
These SNPs occur at mRNA positions 34 (
V12M
; exon 2), 421 (
Q141K
, exon 16), 616 (
I206L
, exon 6) and 1768 (
N590Y
, exon 15).
Login to comment
328
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 17159598:328:12
status:
VERIFIED
view ABCG2 p.Val12Met details
ABCG2 p.Ile206Leu
X
ABCG2 p.Ile206Leu 17159598:328:18
status:
VERIFIED
view ABCG2 p.Ile206Leu details
ABCG2 p.Asn590Tyr
X
ABCG2 p.Asn590Tyr 17159598:328:28
status:
VERIFIED
view ABCG2 p.Asn590Tyr details
The SNPs of
V12M
,
I206L
and
N590Y
have not to date been found to confer an alteration in protein expression or function.
Login to comment
329
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17159598:329:99
status:
VERIFIED
view ABCG2 p.Gln141Lys details
The nonsynonymous substitution C421A, in which a lysine is substituted for glutamine at codon 141 (
Q141K
), has been shown to have a functional significance.
Login to comment
331
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17159598:331:173
status:
VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 17159598:331:153
status:
VERIFIED
view ABCG2 p.Val12Met details
ABCG2 p.Ile206Leu
X
ABCG2 p.Ile206Leu 17159598:331:209
status:
VERIFIED
view ABCG2 p.Ile206Leu details
ABCG2 p.Asn590Tyr
X
ABCG2 p.Asn590Tyr 17159598:331:226
status:
VERIFIED
view ABCG2 p.Asn590Tyr details
Table 12 Ethnic frequencies (%) of allelic variants in ABCG2 gene Allelic variant Caucasians African-Americans Asians Hispanics Africans Middle Easterns
V12M
2 4 20-45 40 5
Q141K
11-14 2.3-5.0 15-35 10 1.0 13
I206L
0 0 0 10 0
N590Y
1 Sources: [150-153].
Login to comment
334
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17159598:334:110
status:
VERIFIED
view ABCG2 p.Gln141Lys details
Plasma concentrations of orally administered drugs, including oral topotecan, are higher in patients with the
Q141K
SNP, which correlates with the protein`s role in drug excretion.
Login to comment